AU7130696A - Combination of beta-interferon for the treatment of prostate cancer - Google Patents

Combination of beta-interferon for the treatment of prostate cancer

Info

Publication number
AU7130696A
AU7130696A AU71306/96A AU7130696A AU7130696A AU 7130696 A AU7130696 A AU 7130696A AU 71306/96 A AU71306/96 A AU 71306/96A AU 7130696 A AU7130696 A AU 7130696A AU 7130696 A AU7130696 A AU 7130696A
Authority
AU
Australia
Prior art keywords
interferon
beta
treatment
combination
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU71306/96A
Inventor
Torsten Strohmeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1995136593 external-priority patent/DE19536593A1/en
Priority claimed from DE1995136818 external-priority patent/DE19536818A1/en
Application filed by Schering AG filed Critical Schering AG
Publication of AU7130696A publication Critical patent/AU7130696A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU71306/96A 1995-09-19 1996-09-17 Combination of beta-interferon for the treatment of prostate cancer Withdrawn AU7130696A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19536593 1995-09-19
DE1995136593 DE19536593A1 (en) 1995-09-19 1995-09-19 Use of an interferon-beta, e.g., a deriv. of human interferon-beta
DE1995136818 DE19536818A1 (en) 1995-09-20 1995-09-20 Use of beta-interferon to treat patients with prostate cancer
DE19536818 1995-09-21
PCT/EP1996/004079 WO1997010842A1 (en) 1995-09-19 1996-09-17 COMBINATION OF β-INTERFERON FOR THE TREATMENT OF PROSTATE CANCER

Publications (1)

Publication Number Publication Date
AU7130696A true AU7130696A (en) 1997-04-09

Family

ID=26019141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71306/96A Withdrawn AU7130696A (en) 1995-09-19 1996-09-17 Combination of beta-interferon for the treatment of prostate cancer

Country Status (2)

Country Link
AU (1) AU7130696A (en)
WO (1) WO1997010842A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642274B1 (en) 1999-09-09 2003-11-04 Gary W. Neal Methods and compositions for preventing and treating prostate disorders
WO2001017479A2 (en) * 1999-09-09 2001-03-15 Androsolutions, Inc. Methods and compositions for preventing and treating prostate disorders
US6428785B1 (en) 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100527A (en) * 1991-01-14 1997-06-10 Endorecherche Inc Prescreening of prostate cancer by serum prostatic specific antigen
DE4128319A1 (en) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz NEW RECOMBINANT HUMAN-IFN-BETA, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM

Also Published As

Publication number Publication date
WO1997010842A1 (en) 1997-03-27

Similar Documents

Publication Publication Date Title
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU4052897A (en) Cancer treatment method
ZA957483B (en) Compounds and methods for the treatment of cancer
AU5750796A (en) System for the treatment of insomnia
AU5586398A (en) Submersive therapy apparatus
AU4473596A (en) Methods of human prostate cancer diagnosis
AU3829895A (en) Methods for treating resistant tumors
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
AU3552399A (en) Recombinant poliovirus for the treatment of cancer
AU2508597A (en) Drug for the treatment of tumours
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU5005697A (en) Methods of preventing breast cancer
AU5300396A (en) Radiation enhanced gene therapy for treatment of tumors
AU2821295A (en) Compositions and methods for the treatment of tumors
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
AU1480497A (en) Cancer treatment
AU7166896A (en) Cancer treatment
GB9509572D0 (en) Cancer therapy
AU3187595A (en) Compounds for the treatment of restenosis
AU8068198A (en) Methods for treating human cancers
AU1979499A (en) Apparatus for therapeutic electromagnetic treatment
MD798F1 (en) Method of the mamma cancer treatment
AU6012696A (en) Prognostic and therapeutic system for cancer
GB9308166D0 (en) Cancer therapy
AU7602896A (en) Methods for treating resistant tumors